All Industries

Top Life Sciences Companies

416 Life Sciences companies, sorted by total funding raised.

OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private Equity·$647.0M·Feb 2026
Color

Population-scale health company delivering genetic testing, cancer screening, and virtual clinica...

Burlingame, United States501–1000Life Sciences, Biotech
Series E·$614.0M·Nov 2021
CRISPR Therapeutics AG Common SharesIPO

Gene editing company using CRISPR/Cas9 technology to develop transformative medicines for serious...

Zug, Switzerland201–500Biotech, Healthcare
Venture Round·$604.5M·Feb 2024
Rakuten Medical

Global biotechnology company developing and commercializing precision, cell-targeting therapies b...

San Diego, United StatesBiotech, Life Sciences
Series F·$575.0M·Jan 2026
LifeMine Therapeutics

Clinical-stage biopharma mining fungal genomes to discover genetically-encoded small molecules fo...

Cambridge, United States51–200Biotech, Drug Discovery
Venture Round·$563.0M·Aug 2026
apprentice.io

Apprentice.io is an intelligent software company that builds solutions for global life science te...

Jersey City, United States51–200Life Sciences, Manufacturing Software
Series E·$562.0M·Jan 2025
Centessa PharmaceuticalsIPO

Centessa Pharmaceuticals is a next-gen biopharmaceutical company reshaping traditional drug devel...

United States51–200Healthcare, Life Sciences
Corporate Round·$550.0M·Apr 2024
Sanfer

Sanfer is an independent pharmaceutical company based in Mexico, and operating in nine countries ...

Mexico City, Mexico10001+Life Sciences
Growth Equity·$500.0M·Aug 2019
SynthegoAcquired

Provides CRISPR reagents, engineered nucleases, and GMP manufacturing to researchers and therapeu...

Redwood City, United States51–200Biotech, Genomics
Series E·$468.6M·Feb 2022
ArvinasIPO

Clinical-stage biotechnology company developing PROTAC protein degraders for oncology and neurode...

New Haven, United States201–500Biotech, Healthcare
Private Equity·$464.9M·Nov 2023
Sword

Sword offers virtual physical therapy services through a combination of AI and human expertise.

New York, United States501–1000Life Sciences, Artificial Intelligence
Venture Round·$464.6M·Jun 2025
BiofourmisAcquired

AI-driven platform delivering remote patient monitoring and in-home care for health systems, paye...

Boston, United States201–500Artificial Intelligence, Digital Health
Series D·$461.5M·Jul 2022
AlumisMerged

Alumis is a late-stage biopharma company developing targeted therapies for patient with immune-me...

South San Francisco, United States201–500Healthcare, Life Sciences
Series C·$459.0M·Mar 2024
Crinetics Pharmaceuticals, Inc.

R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.

San Diego, United States11–50Biotech, Healthcare
Venture Round·$453.5M·Jan 2026
Capital Rx

Full-service pharmacy benefits manager and administrator serving employers and health plans with ...

New York, United States501–1000Life Sciences, Healthcare
Series F·$452.3M·Sep 2025
GalectoIPO

Clinical-stage biotech developing small-molecule therapeutics targeting galectin and other mechan...

Copenhagen, Denmark11–50Biotech, Drug Development
Series C·$446.9M·Nov 2025
Charles River Laboratories InternationalIPO

Global contract research organization providing preclinical testing, clinical development, and ma...

Wilmington, United States10001+Contract Research, Healthcare
Private Equity·$443.0M·Sep 1999
AvalynIPO

Developing inhaled therapies to treat people with severe respiratory disease.

Boston, United States11–50Biotech, Healthcare
Series D·$434.5M·Jul 2025
Areteia TherapeuticsClosed

Clinical-stage biotechnology developing an oral eosinophil-maturation inhibitor (dexpramipexole) ...

Chapel Hill, United States11–50Biotech, Life Sciences
Series A·$425.0M·Feb 2024
Transcarent

Transcarent is the One Place for Health and Care that makes it easy for people to access high-qua...

San Francisco, United States501–1000Life Sciences, Artificial Intelligence
Series D·$424.0M·May 2024
Verdiva Bio

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therap...

London, United Kingdom11–50Life Sciences, Biotech
Series A·$411.0M·Jan 2025
Sonoma Biotherapeutics

Develops engineered regulatory T cell therapies to restore immune balance and treat autoimmune an...

Seattle, United States51–200Biotech, Life Sciences
Corporate Round·$410.0M·Sep 2024
Elemy

Provider of in-home and online pediatric behavioral health and autism care, offering personalized...

San Francisco, United States51–200Digital Health, Healthcare
Series B·$364.0M·Oct 2021
Umoja

Develops in vivo CAR T cell therapies that generate CAR T cells inside patients to treat cancer.

Seattle, United States201–500Biotech, Drug Discovery
Series C·$363.0M·Jan 2025
Dewpoint Therapeutics

Biotech company applying biomolecular condensate science to drug discovery across oncology, neuro...

Boston, United States51–200Life Sciences, Biotech
Series D·$346.1M·Sep 2025